Prostacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis in children.
Open Access
- 1 October 1991
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 66 (10) , 1231-1234
- https://doi.org/10.1136/adc.66.10.1231
Abstract
The role of prostacyclin in the pathogenesis of haemolytic uraemic syndrome was evaluated in 11 children with acute shigellosis. Plasma concentrations of 6-keto prostaglandin, F1 alpha, a stable metabolite of prostacyclin, were measured by radioimmunoassay during acute illness, early convalescence, and after clinical recovery. Its concentration was low during acute illness in each patient, returning to normal concentrations or above at the time of the last sample. These results suggest that plasma prostacyclin may be involved in the development of the syndrome.Keywords
This publication has 16 references indexed in Scilit:
- Lisch Nodules in Neurofibromatosis Type 1New England Journal of Medicine, 1991
- Prostanoids in hemolytic uremic syndromeThe Journal of Pediatrics, 1985
- Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome.Archives of Disease in Childhood, 1983
- Prostacyclin infusion in haemolytic-uraemic syndrome of children.BMJ, 1981
- Prostacyclin deficiency in haemolytic-uraemic syndrome.BMJ, 1980
- HqMOLYTIC-URqMIC SYNDROME: DEFICIENCY OF PLASMA FACTOR(S) REGULATING PROSTACYCLIN ACTIVITY?The Lancet, 1978
- Haemolytic-uraemic syndrome complicating shigella dystentery in south Indian children.BMJ, 1978
- Hemolytic-Uremic Syndrome after ShigellosisNew England Journal of Medicine, 1978
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- The hemolytic-uremic syndromeThe Journal of Pediatrics, 1964